Masahiro Yamamoto
Overview
Explore the profile of Masahiro Yamamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
653
Citations
20960
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakayama Y, Sasai M, Kuratani A, Okamoto M, Okuzaki D, Yamamoto K, et al.
iScience
. 2025 Mar;
28(3):111975.
PMID: 40060898
Alveolar macrophages (AMs) are essential for maintaining lung homeostasis. However, their roles in respiratory infections have been controversial because the methods of depleting them have often suffered from poor cell...
2.
Taguchi S, Kawai T, Kurokawa Y, Saegusa N, Yamamoto M, Ambe Y, et al.
Int J Clin Oncol
. 2025 Mar;
PMID: 40032741
Background: Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (dd-MVAC) is an established regimen for advanced urothelial carcinoma (aUC). Although platinum-based chemotherapy, typically gemcitabine and cisplatin, followed by switch maintenance avelumab has...
3.
Ichihara Y, Okawa M, Minegishi M, Oizumi H, Yamamoto M, Ohbuchi K, et al.
Medicines (Basel)
. 2025 Jan;
12(1.
PMID: 39846712
Introduction: In the central nervous system (CNS), proper interaction between neuronal and glial cells is crucial for the development of mature nervous tissue. Hypomyelinating leukodystrophies (HLDs) are a group of...
4.
Guo L, Shiohara K, Yamaguchi H, Wang G, Okabe Y, Nakatake M, et al.
Sci Rep
. 2025 Jan;
15(1):2900.
PMID: 39843967
Alkali antimonide semiconductor photocathodes are promising candidates for high-brightness electron sources for advanced accelerators, including free-electron lasers (FEL), due to their high quantum efficiency (QE), low emittance, and high temporal...
5.
Kawai T, Kurokawa Y, Taguchi S, Honda K, Maki K, Ambe Y, et al.
Jpn J Clin Oncol
. 2025 Jan;
PMID: 39812300
Background: Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (dd-MVAC) regimen has been established as a systemic chemotherapy for patients with urothelial carcinoma. However, it is rarely used in Japan owing to...
6.
Ogawa N, Yamamoto M, Kobayashi R, Kawamura A, Matsumoto A, Otani H, et al.
J Bone Miner Metab
. 2025 Jan;
PMID: 39806228
Introduction: Despite many studies on the prevalence of vertebral fractures (VFs), the VF prevalence at death in the Japanese population remains unclear. Materials And Methods: We evaluated the VF prevalence...
7.
Kuyama N, Izumiya Y, Takashio S, Usuku H, Tabira A, Oguni T, et al.
Circ J
. 2025 Jan;
PMID: 39779224
Background: Accurate prediction of prognosis in transthyretin amyloid cardiomyopathy (ATTR-CM) is crucial for optimal treatment selection, including tafamidis, the only approved therapy for ATTR-CM. Although tafamidis has been proven to...
8.
Yamamoto M, Morishima K, Endo K, Shimodaira K, Kimura Y, Aoki Y, et al.
Cureus
. 2024 Dec;
16(11):e73864.
PMID: 39691153
Introduction: Hepatic resection (HR) and radiofrequency ablation (RFA) are curative treatments for three or fewer hepatocellular carcinomas in Japan. The laparoscopic approach in both has been used in recent years;...
9.
Soga Y, Kamiyama N, Ozaki T, Chalalai T, Sachi N, Ozaka S, et al.
Biochem Biophys Res Commun
. 2024 Dec;
743:151085.
PMID: 39689644
Lipid mediator, palmitoylethanolamide (PEA) has recently attracted attention as a potential therapeutic option for various inflammatory autoimmune diseases. It has been reported that PEA exerts an inhibitory effect on inflammation...
10.
Tachibana Y, Yamamoto M
Parasitol Int
. 2024 Nov;
105:102997.
PMID: 39586398
The apicomplexan parasite, Toxoplasma gondii, develops unique secretory organelles, such as micronemes, rhoptries, and dense granules, which do not exist in other well-studied eukaryotic organisms. These secretory organelles are key...